Search Results - "Ohira, Takehiro"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    AL-Kappa Primary Amyloidosis with Apolipoprotein A-IV Deposition by Ishimitsu, Akira, Tojo, Akihiro, Hirao, Jun, Yokoyama, Shohei, Ohira, Takehiro, Murayama, Yoshiki, Ishimitsu, Toshihiko, Kang, Dedong, Honda, Kazuho, Ehara, Takashi, Ishida, Kazuyuki, Ueda, Yoshihiko

    Published in Internal Medicine (15-03-2022)
    “…A 70-year-old woman with complaints of edema, general malaise, and hypotension was diagnosed with renal amyloidosis, and laser microdissection mass…”
    Get full text
    Journal Article
  2. 2

    Urinary Podocyte Excretion Predicts Urinary Protein Selectivity and Renal Prognosis by Abe, Makoto, Kaiga, Akiko, Ohira, Takehiro, Ishimitsu, Toshihiko, Tojo, Akihiro

    Published in International journal of nephrology (29-06-2022)
    “…Background. Urinary podocyte excretion is related to a reduction in glomerular podocyte numbers, glomerulosclerosis, and urinary protein selectivity. To…”
    Get full text
    Journal Article
  3. 3

    Juvenile Membranous Nephropathy Developed after Human Papillomavirus (HPV) Vaccination by Arakawa, Haruna, Yokoyama, Shohei, Ohira, Takehiro, Kang, Dedong, Honda, Kazuho, Ueda, Yoshihiko, Tojo, Akihiro

    Published in Vaccines (Basel) (01-09-2022)
    “…A 16-year-old girl with no history of renal disease had a fever of 38 °C after her second HPV vaccination and was identified as positive for proteinuria. As…”
    Get full text
    Journal Article
  4. 4

    Effects of atorvastatin and ezetimibe on endothelial function in dyslipidemic patients with chronic kidney disease by Ishimitsu, Toshihiko, Ohno, Eri, Ueno, Yasuhiko, Onoda, Shou, Nagase, Akihiko, Ohira, Takehiro, Nakano, Nobuyuki, Satonaka, Hiroshi

    Published in Clinical and experimental nephrology (01-10-2014)
    “…Backgroud Chronic kidney disease (CKD) is a staple risk factor not only for renal failure but also for cardiovascular diseases. In addition, because…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Rituximab in treatment of anti-GBM antibody glomerulonephritis: A case report and literature review by Uematsu-Uchida, Mayu, Ohira, Takehiro, Tomita, Shigeki, Satonaka, Hiroshi, Tojo, Akihiro, Ishimitsu, Toshihiko

    Published in Medicine (Baltimore) (01-11-2019)
    “…Anti-glomerular basement membrane (GBM) disease is a T cell-mediated disease that has a poor prognosis with conventional therapy. We tested rituximab as a…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9